AIIMS Delhi, Blockchain For Impact to advance biomedical innovation in India

AIIMS and BFI Unite to Combat Recurrent UTIs

AIIMS Delhi has partnered with Blockchain For Impact (BFI) to enhance biomedical research and innovation in India. The collaboration will focus on identifying potential markers for recurrent urinary tract infections (rUTI). Dec 20, 2024
1st malaria vaccine shows promise against rising cases: Report

Promising results for world's first Malaria vaccine RH5.1/Matrix-M: Report

The global fight against malaria has taken a significant leap forward with the development of the first blood-stage malaria vaccine, RH5.1/Matrix-M. According to a report released by GlobalData, a leading data and analytics company, the vaccine has shown promising results and could play a crucial role in the evolving strategy against malaria. Dec 19, 2024
MEDICINE

India Becomes Third Largest Pharma Market Globally

India's pharmaceutical industry, valued at $50 billion, is the third largest globally by volume, with a strong global presence and diversified product base. The Department of Pharmaceuticals has established seven National Institutes of Pharmaceutical Education and Research (NIPERs) for high-end research and education. Dec 19, 2024
Cure.fit

CureFit Suffers ₹888 Crore Loss in Financial Year 2024

The recent financial disclosure from CureFit, a leading fitness startup, has raised eyebrows in the business community. The company's consolidated loss for the fiscal year 2024 has seen a significant surge of 42%, amounting to Rs 888.5 crore, a substantial increase from Rs 625.5 crore in the previous fiscal year. This increase in losses is primarily attributed to the company's high cash burn rate. Dec 17, 2024